Management of Positive Cologuard Results

Immediate Diagnostic Follow‑up

• An abnormal Cologuard (stool DNA) test should never be repeated; the patient should be referred directly to diagnostic colonoscopy. (American Cancer Society guideline) 1
• A positive stool DNA result mandates colonoscopy as the sole appropriate next step; no additional stool‑based testing is justified. (American Cancer Society guideline) 1
• Repeating FOBT or stool DNA testing after an initial positive result has no clinical justification. (American Cancer Society guideline) 1
• Colonoscopy provides substantially higher accuracy for detecting colorectal cancer and adenomas compared with flexible sigmoidoscopy, barium enema, or CT colonography. (Praxis Medical Insights) 2
• In patients with a positive stool‑based test, colonoscopy detects cancer in roughly 10 % and adenomatous polyps in about 37 % of cases. (Praxis Medical Insights) 2

Timing of Follow‑up Colonoscopy

• Diagnostic colonoscopy should be completed within 60 days of a positive Cologuard result. (American Cancer Society guideline, 2018) 4
• Performing colonoscopy earlier reduces the risk of progression from pre‑neoplastic disease to invasive cancer and from early‑stage to late‑stage disease. (American Cancer Society guideline, 2018) 4
• Prolonged waiting periods increase the likelihood that patients will lose contact information, insurance coverage, or provider continuity, jeopardizing follow‑up. (American Cancer Society guideline, 2018) 4
• Even in highly organized screening programs, the proportion of patients who undergo colonoscopy after a positive fecal test plateaus at ≈ 80 % after six months. (American Cancer Society guideline, 2018) 4

Interventions to Avoid

• Flexible sigmoidoscopy alone is inadequate because it examines only part of the colon and cannot remove all significant neoplasia. (Praxis Medical Insights) 2
• Barium enema should not be used as a substitute; colonoscopy remains the gold‑standard complete evaluation. (Praxis Medical Insights) 2
• CT colonography is not appropriate as the initial follow‑up for a positive stool DNA test; a direct colonoscopy is indicated. (Praxis Medical Insights) 2
• Collecting a single stool sample on the clinician’s fingertip during a digital rectal exam is not recommended. (American Cancer Society guideline) 1

Patient Communication Essentials

• Colonoscopy is required regardless of the presence or absence of symptoms. (Praxis Medical Insights) 2
• The procedure simultaneously diagnoses and treats colorectal polyps, eliminating the need for separate therapeutic interventions. (Praxis Medical Insights) 2

Post‑Colonoscopy Surveillance

• Surveillance intervals are determined by polyp number, size, and histology (e.g., high‑risk adenomas warrant shorter intervals). (Praxis Medical Insights) 2
• Patients in whom one or more adenomas are identified should enter a regular surveillance program to detect metachronous adenomatous polyps. (Praxis Medical Insights) 3

Age‑Specific Screening Recommendations (Average‑Risk Adults)

• Start screening at age 45 for average‑risk adults, per USPSTF guidance. (U.S. Preventive Services Task Force, Grade A) 5
• Continue screening through age 75 (Grade A recommendation). (U.S. Preventive Services Task Force, Grade A) 5
• For adults aged 76–85, screening decisions should be individualized based on overall health, life expectancy, comorbidities, and prior screening history. (U.S. Preventive Services Task Force) 5
• Discontinue screening after age 85. (U.S. Preventive Services Task Force) 5